(Q71693371)
Statements
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group (English)
Katlama C
Mouthon B
Gourdon D
Lapierre D
1 September 1996